David Perryman

• 
  www.needlerosenberg.com/PGIndTeam.aspx?id=6 - [Cached Version]
  Published on: 3/16/2007    Last Visited: 3/16/2007  

  David G. Perryman, J.D.

• 
  www.needlerosenberg.com/StaffInd.aspx?id=32 - [Cached Version]
  Published on: 3/16/2007    Last Visited: 3/16/2007  

  David G. Perryman, J.D.Needle & Rosenberg - Professionals
  ...
  David Perryman is a shareholder at Needle & Rosenberg, P.C., and has been exclusively practicing biotech patent law since 1986.David joined N&R in 1991 and focuses on helping clients position their intellectual property (IP) in a manner consistent with their business goals so that costs are avoided and value is found or created.He also works to analyze patent positions and navigate the competitor's Patentscape®, to maximize client business leverage and minimize pitfalls.
  
  David currently serves on the board of directors for Southeast Bio and for several biotechnology companies, delivering IP business strategies to the highest levels of management.He has written and lectured on IP business strategy to corporate thought-leaders, in-house counsel and scientists.
  
  In addition to his law degree, David has an undergraduate degree in Genetics backed up by more than fifteen years of focus on cutting edge science in the biotechnology industry.As a charter member of the Biotechnology Committee of the American Intellectual Property Law Association, he is an "old-timer" to the legal side of biotechnology.He is admitted to practice and has practiced biotechnology patent law in California, Georgia and New York.
  
  David's peers in the legal community voted him a Georgia Trend magazine Legal Elite in 2004 and a Georgia Super Lawyer each year from 2004 - 2007.He was also chosen as one of the best intellectual property lawyers in Atlanta in the specialty of Biotechnology Law to the 2007 edition of The Best Lawyers in America®.David is married, has three children and coaches both baseball and soccer.
  
  "I believe that it is the journey in life that matters and that providing value to clients that I know well and care about is critical to making that journey a happy one."
  
  dperryman@needlerosenberg.com
  
  Click to contact David G. Perryman, J.D.

• 
  www.needlepatent.com/StaffInd.aspx?id=32 - [Cached Version]
  Published on: 1/28/2006    Last Visited: 3/16/2007  

  David G. Perryman, J.D.Needle & Rosenberg - Professionals
  ...
  David G. Perryman J.D.
  
  David Perryman is a shareholder at Needle & Rosenberg, P.C., and has been exclusively practicing biotech patent law since 1986.David joined N&R in 1991 and focuses on helping clients position their intellectual property (IP) in a manner consistent with their business goals so that costs are avoided and value is found or created.He also works to analyze patent positions and navigate the competitor's Patentscape®, to maximize client business leverage and minimize pitfalls.
  
  David currently serves on the board of directors for Southeast Bio and for several biotechnology companies, delivering IP business strategies to the highest levels of management.He has written and lectured on IP business strategy to corporate thought-leaders, in-house counsel and scientists.
  
  In addition to his law degree, David has an undergraduate degree in Genetics backed up by more than fifteen years of focus on cutting edge science in the biotechnology industry.As a charter member of the Biotechnology Committee of the American Intellectual Property Law Association, he is an "old-timer" to the legal side of biotechnology.He is admitted to practice and has practiced biotechnology patent law in California, Georgia and New York.
  
  David's peers in the legal community voted him a Georgia Trend magazine Legal Elite in 2004 and a Georgia Super Lawyer each year from 2004 - 2007.He was also chosen as one of the best intellectual property lawyers in Atlanta in the specialty of Biotechnology Law to the 2007 edition of The Best Lawyers in America®.David is married, has three children and coaches both baseball and soccer.
  
  "I believe that it is the journey in life that matters and that providing value to clients that I know well and care about is critical to making that journey a happy one."
  
  dperryman@needlerosenberg.com
  
  Click to contact David G. Perryman, J.D.

• 
  www.needlerosenberg.com/StaffList.aspx?lid=Full - [Cached Version]
  Published on: 3/16/2007    Last Visited: 3/16/2007  

  David G. Perryman, J.D.

• 
  www.needlerosenberg.com/StaffContact.aspx?id=32 - [Cached Version]
  Published on: 3/16/2007    Last Visited: 3/16/2007  

  Click to contact David G. Perryman, J.D.Needle & Rosenberg - Professionals
  ...
  David G. Perryman

• 
  www.bioalabama.com/show_member.php?id=124 - [Cached Version]
  Published on: 6/6/2004    Last Visited: 6/6/2004  

  David G. Perryman Needle & Rosenberg, P.C.
  ...
  Mr David G. Perryman
  
  Needle & Rosenberg, P.C.127 Peachtree Street, NESuite 1200Atlanta, Georgia 30303404-688-0770404-688-9880

• 
  www.needlepatent.com/PRInd.aspx?id=7 - [Cached Version]
  Published on: 12/3/2002    Last Visited: 3/16/2007  

  Seven years later, with the support of Needle & Rosenberg and its biotechnology practice group leader, David Perryman (also a member of Maxia's Board of Directors), Maxia has just been acquired by Incyte Genomics, Inc.

• 
  Management - [Cached Version]
  Published on: 8/23/2009    Last Visited: 8/23/2009  

  David Perryman joined our board in late 2005. He is a shareholder at Needle & Rosenberg, P.C., one of the largest intellectual property law firms in the Southeast USA. David serves on the board of directors for several biotechnology companies, is a charter member of the Biotechnology Committee of the American Intellectual Property Law Association and was recently voted as one of Georgia Trend magazine's "Legal Elite". David has been a founder of four biotechnology companies and has provided focus to shareholder value creation in these early stage companies.

• 
  Needle & Rosenberg - Press Releases - [Cached Version]
  Published on: 2/19/2004    Last Visited: 6/18/2008  

  Needle & Rosenberg shareholder David Perryman will be meeting with interested companies in 30-minute time slots to answer questions and provide information in matters related to IP and licensing.*
  
  Perryman leads Needle & Rosenberg's biotechnology practice.He has been practicing biotech patent law exclusively since 1986 and has been with Needle & Rosenberg since 1991.He is admitted to the bar and has practiced biotechnology patent law in California, Georgia and New York.Perryman is an experienced entrepreneur, having co-founded a number of biotech companies.He currently serves on the board of directors for several companies in the industry.
  
  "The Pharma License Exchangeâ„¢ partnering forum offers pharma and biotech companies a uniquely efficient chance to explore valuable business development and licensing opportunities and to initiate the deal making process," says Perryman.

• 
  Needle & Rosenberg - Press Releases - [Cached Version]
  Published on: 2/19/2004    Last Visited: 6/17/2008  

  Needle & Rosenberg shareholder David Perryman will be meeting with interested companies in 30-minute time slots to answer questions and provide information in matters related to IP and licensing.*
  
  Perryman leads Needle & Rosenberg's biotechnology practice.He has been practicing biotech patent law exclusively since 1986 and has been with Needle & Rosenberg since 1991.He is admitted to the bar and has practiced biotechnology patent law in California, Georgia and New York.Perryman is an experienced entrepreneur, having co-founded a number of biotech companies.He currently serves on the board of directors for several companies in the industry.
  
  "The Pharma License Exchangeâ„¢ partnering forum offers pharma and biotech companies a uniquely efficient chance to explore valuable business development and licensing opportunities and to initiate the deal making process," says Perryman.

Page:  1 2